There's no treatment designed for the Ebola strain ravaging DRC. But now there's hope
Clinical trials are underway to test repurposed drugs against the Bundibugyo strain of Ebola in the Democratic Republic of Congo. This effort aims to address the lack of specialized treatments for this rare and deadly virus.
Why it matters
Developing rapid responses to rare viral outbreaks is critical to preventing large-scale loss of life in vulnerable regions.
It's been over 50 days since the Ebola outbreak was declared in the Democratic Republic of Congo and Uganda. Clinicians on the ground are working to save dying patients, but they lack crucial tools to fight the kind of Ebola that's spreading.
The article provides a factual, objective report on medical research and public health efforts without political framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in